The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Infection & Hospitalization in SLE

Infection & Hospitalization in SLE

August 4, 2015 • By Arthritis Care & Research

  • Tweet
  • Email
Print-Friendly Version / Save PDF

According to findings published in the August 2015 issue of Arthritis Care & Research, “The risk of hospitalization for … serious infections, [such as pneumonia and sepsis], ranged from 12 to 24 times higher in patients with systemic lupus erythematosus (SLE) than in the general population.”

You Might Also Like
  • Infection Rates for Patients with SLE on Immunosuppressive Drugs
  • SLE Patients May Not Receive Enough Cardiovascular Disease Assessment & Treatment
  • Newly Diagnosed SLE Patients Have a Greater Risk of Cardiovascular Disease

Maria G. Tektonidou, MD, and colleagues from the First Department of Internal Medicine, School of Medicine, University of Athens, used 1996–2011 data from the Nationwide Inpatient Sample (NIS) from the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality  to examine the risks and burdens of serious infectious diseases in U.S. adult patients with SLE compared with the general population. For both SLE and non-SLE populations, the researchers examined trends in the hospitalization and in-hospital mortality for five infections: pneumonia, sepsis, urinary tract infections, skin and soft-tissue infections, and opportunistic infections.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Over the past two decades, hospitalization for infections increased substantially for SLE patients and is 12 times more likely when compared with non-SLE patients. The data showed that pneumonia was the most commonly occurring infection, with incidence of hospitalization increasing from 3.1% in 1996 to 5.4% in 2011. Also, rates for sepsis and skin infections tripled in that time. For the general population, hospitalization rates also increased greatly, with a 52% increase for skin infections and a 190% increase for sepsis. These rates in the non-SLE population are attributed to an aging population, comorbidities and a greater use of medical interventions.

Additionally, researchers found that in-hospital mortality decreased over the course of the study period, which may reflect advances in diagnosis and management or the admission of less ill patients. SLE patients with opportunistic infections had the highest in-hospital risk of death. And the use of medical ventilation was also associated with a high risk of mortality for SLE patients with opportunistic infections, severe pneumonia and severe sepsis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Infections remain a source of morbidity for patients with SLE, and the cause(s) of this accelerated infection rate remains unclear. Researchers suspect that the use of immunosuppressive medications might play a role. They also note that, like the general population, SLE patients are living longer, with more comorbidities, as well as organ damage, increasing the risk of infection.

Read the full article.

Tektonidou MG, Wang Z, Dasgupta A, Ward MM. Burden of serious infections in adults with systemic lupus erythematosus: A national population-based study, 1996–2011. Arthritis Care Res (Hoboken). 2015 Aug;67(8):1078–1085.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: Arthritis Care & Research, hospital, Infection, systemic lupus erythematosus (SLE)

You Might Also Like:
  • Infection Rates for Patients with SLE on Immunosuppressive Drugs
  • SLE Patients May Not Receive Enough Cardiovascular Disease Assessment & Treatment
  • Newly Diagnosed SLE Patients Have a Greater Risk of Cardiovascular Disease
  • Researchers Calculate Comorbidity Burden for Patients with SLE

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.